Mutation of the phospholipase catalytic domain of the Pseudomonas aeruginosa cytotoxin ExoU abolishes colonization promoting activity and reduces corneal disease severity

C. Tam, S. E. Lewis, W. Y. Li, Ellen Lee, D. J. Evans, S. M J Fleiszig

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

We have previously shown that ExoU, a type III secreted cytotoxin of Pseudomonas aeruginosa, causes acute cytotoxicity towards corneal epithelial cells in vitro, and contributes to corneal disease pathology and ocular colonization in vivo. Subsequently, we reported that ExoU represses phagocyte infiltration of infected corneas in vivo. ExoU has patatin-like phospholipase activity that is required for cytotoxic activity in vitro (mammalian cell injury and death) and for disease in a murine model of pneumonia. We hypothesized that the phospholipase activity was required for ExoU-mediated corneal disease and ocular colonization. Using the murine scarification model, corneal disease pathology was examined after inoculation with ∼106 cfu of a P. aeruginosa effector mutant (PA103ΔexoUexoT::Tc) complemented with either exoU (pUCPexoU), phospholipase-inactive exoU (pUCPexoUD344A) or a plasmid control (pUCP18). Eyes were photographed and disease severity scored at 24 and 48 h post-infection. Viable bacteria colonizing infected eyes were quantified at 6 and 48 h. Complementation with exoU caused significantly more pathology (increased disease severity scores) and enabled bacteria to better colonize (by ∼1000-fold) at 48 h as compared to phospholipase-inactive exoU which did not differ from plasmid control. Surprisingly, exoU did not contribute to early (6 h) colonization. In-vitro assays confirmed that the phospholipase domain of exoU was required for cytotoxicity towards human corneal epithelial cells. Taken together these data show that the phospholipase activity of the P. aeruginosa cytotoxin, ExoU, plays a role in the pathogenesis of corneal infection via mechanism(s) occurring after initial colonization of a susceptible cornea.

Original languageEnglish (US)
Pages (from-to)799-805
Number of pages7
JournalExperimental Eye Research
Volume85
Issue number6
DOIs
StatePublished - Dec 2007
Externally publishedYes

Fingerprint

Corneal Diseases
Phospholipases
Catalytic Domain
Mutation
Pathology
Cornea
Plasmids
Epithelial Cells
Bacteria
Phagocytes
Infection
Pseudomonas aeruginosa
Pseudomonas aeruginosa Cytotoxins
Pneumonia
Cell Death
Wounds and Injuries
In Vitro Techniques

Keywords

  • ExoU
  • keratitis
  • P. aeruginosa
  • phospholipase
  • type III secretion
  • virulence

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems

Cite this

Mutation of the phospholipase catalytic domain of the Pseudomonas aeruginosa cytotoxin ExoU abolishes colonization promoting activity and reduces corneal disease severity. / Tam, C.; Lewis, S. E.; Li, W. Y.; Lee, Ellen; Evans, D. J.; Fleiszig, S. M J.

In: Experimental Eye Research, Vol. 85, No. 6, 12.2007, p. 799-805.

Research output: Contribution to journalArticle

@article{4b8df138252e4c31aa1906907472704c,
title = "Mutation of the phospholipase catalytic domain of the Pseudomonas aeruginosa cytotoxin ExoU abolishes colonization promoting activity and reduces corneal disease severity",
abstract = "We have previously shown that ExoU, a type III secreted cytotoxin of Pseudomonas aeruginosa, causes acute cytotoxicity towards corneal epithelial cells in vitro, and contributes to corneal disease pathology and ocular colonization in vivo. Subsequently, we reported that ExoU represses phagocyte infiltration of infected corneas in vivo. ExoU has patatin-like phospholipase activity that is required for cytotoxic activity in vitro (mammalian cell injury and death) and for disease in a murine model of pneumonia. We hypothesized that the phospholipase activity was required for ExoU-mediated corneal disease and ocular colonization. Using the murine scarification model, corneal disease pathology was examined after inoculation with ∼106 cfu of a P. aeruginosa effector mutant (PA103ΔexoUexoT::Tc) complemented with either exoU (pUCPexoU), phospholipase-inactive exoU (pUCPexoUD344A) or a plasmid control (pUCP18). Eyes were photographed and disease severity scored at 24 and 48 h post-infection. Viable bacteria colonizing infected eyes were quantified at 6 and 48 h. Complementation with exoU caused significantly more pathology (increased disease severity scores) and enabled bacteria to better colonize (by ∼1000-fold) at 48 h as compared to phospholipase-inactive exoU which did not differ from plasmid control. Surprisingly, exoU did not contribute to early (6 h) colonization. In-vitro assays confirmed that the phospholipase domain of exoU was required for cytotoxicity towards human corneal epithelial cells. Taken together these data show that the phospholipase activity of the P. aeruginosa cytotoxin, ExoU, plays a role in the pathogenesis of corneal infection via mechanism(s) occurring after initial colonization of a susceptible cornea.",
keywords = "ExoU, keratitis, P. aeruginosa, phospholipase, type III secretion, virulence",
author = "C. Tam and Lewis, {S. E.} and Li, {W. Y.} and Ellen Lee and Evans, {D. J.} and Fleiszig, {S. M J}",
year = "2007",
month = "12",
doi = "10.1016/j.exer.2007.08.015",
language = "English (US)",
volume = "85",
pages = "799--805",
journal = "Experimental Eye Research",
issn = "0014-4835",
publisher = "Academic Press Inc.",
number = "6",

}

TY - JOUR

T1 - Mutation of the phospholipase catalytic domain of the Pseudomonas aeruginosa cytotoxin ExoU abolishes colonization promoting activity and reduces corneal disease severity

AU - Tam, C.

AU - Lewis, S. E.

AU - Li, W. Y.

AU - Lee, Ellen

AU - Evans, D. J.

AU - Fleiszig, S. M J

PY - 2007/12

Y1 - 2007/12

N2 - We have previously shown that ExoU, a type III secreted cytotoxin of Pseudomonas aeruginosa, causes acute cytotoxicity towards corneal epithelial cells in vitro, and contributes to corneal disease pathology and ocular colonization in vivo. Subsequently, we reported that ExoU represses phagocyte infiltration of infected corneas in vivo. ExoU has patatin-like phospholipase activity that is required for cytotoxic activity in vitro (mammalian cell injury and death) and for disease in a murine model of pneumonia. We hypothesized that the phospholipase activity was required for ExoU-mediated corneal disease and ocular colonization. Using the murine scarification model, corneal disease pathology was examined after inoculation with ∼106 cfu of a P. aeruginosa effector mutant (PA103ΔexoUexoT::Tc) complemented with either exoU (pUCPexoU), phospholipase-inactive exoU (pUCPexoUD344A) or a plasmid control (pUCP18). Eyes were photographed and disease severity scored at 24 and 48 h post-infection. Viable bacteria colonizing infected eyes were quantified at 6 and 48 h. Complementation with exoU caused significantly more pathology (increased disease severity scores) and enabled bacteria to better colonize (by ∼1000-fold) at 48 h as compared to phospholipase-inactive exoU which did not differ from plasmid control. Surprisingly, exoU did not contribute to early (6 h) colonization. In-vitro assays confirmed that the phospholipase domain of exoU was required for cytotoxicity towards human corneal epithelial cells. Taken together these data show that the phospholipase activity of the P. aeruginosa cytotoxin, ExoU, plays a role in the pathogenesis of corneal infection via mechanism(s) occurring after initial colonization of a susceptible cornea.

AB - We have previously shown that ExoU, a type III secreted cytotoxin of Pseudomonas aeruginosa, causes acute cytotoxicity towards corneal epithelial cells in vitro, and contributes to corneal disease pathology and ocular colonization in vivo. Subsequently, we reported that ExoU represses phagocyte infiltration of infected corneas in vivo. ExoU has patatin-like phospholipase activity that is required for cytotoxic activity in vitro (mammalian cell injury and death) and for disease in a murine model of pneumonia. We hypothesized that the phospholipase activity was required for ExoU-mediated corneal disease and ocular colonization. Using the murine scarification model, corneal disease pathology was examined after inoculation with ∼106 cfu of a P. aeruginosa effector mutant (PA103ΔexoUexoT::Tc) complemented with either exoU (pUCPexoU), phospholipase-inactive exoU (pUCPexoUD344A) or a plasmid control (pUCP18). Eyes were photographed and disease severity scored at 24 and 48 h post-infection. Viable bacteria colonizing infected eyes were quantified at 6 and 48 h. Complementation with exoU caused significantly more pathology (increased disease severity scores) and enabled bacteria to better colonize (by ∼1000-fold) at 48 h as compared to phospholipase-inactive exoU which did not differ from plasmid control. Surprisingly, exoU did not contribute to early (6 h) colonization. In-vitro assays confirmed that the phospholipase domain of exoU was required for cytotoxicity towards human corneal epithelial cells. Taken together these data show that the phospholipase activity of the P. aeruginosa cytotoxin, ExoU, plays a role in the pathogenesis of corneal infection via mechanism(s) occurring after initial colonization of a susceptible cornea.

KW - ExoU

KW - keratitis

KW - P. aeruginosa

KW - phospholipase

KW - type III secretion

KW - virulence

UR - http://www.scopus.com/inward/record.url?scp=36448949057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36448949057&partnerID=8YFLogxK

U2 - 10.1016/j.exer.2007.08.015

DO - 10.1016/j.exer.2007.08.015

M3 - Article

C2 - 17905228

AN - SCOPUS:36448949057

VL - 85

SP - 799

EP - 805

JO - Experimental Eye Research

JF - Experimental Eye Research

SN - 0014-4835

IS - 6

ER -